Xeris Biopharma Holdings Insider Sold Shares Worth $250,000, According to a Recent SEC Filing

MT newswire2026/09/29 21:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

05:05 PM EDT, 09/29/2026 (MT Newswires) -- Kevin McCulloch, President and Chief Operating Officer, on September 28, 2026, sold 25,000 shares in Xeris Biopharma Holdings (XERS) for $250,000. Following the Form 4 filing with the SEC, McCulloch has control over a total of 1,639,208 common shares of the company, with 1,614,208 shares held directly and 25,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1867096/000186709626000078/xslF345X05/wk-form4_1790715570.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Xeris Biopharma Holdings Insider Sold Shares Worth $250,000, According to a Recent SEC Filing

You may also like

Crypto prices